Impact of diabetes mellitus on mortality in patients with acute exacerbation of chronic obstructive Pulmonary disease: a meta-analysis and systematic review - Report - MDSpire

Impact of diabetes mellitus on mortality in patients with acute exacerbation of chronic obstructive Pulmonary disease: a meta-analysis and systematic review

  • By

  • Dongmei Zhang

  • Hongbo Zhou

  • Xiujuan Yang

  • Dajian Xia

  • May 13, 2026

  • 0 min

Share

Clinical Report: Effects of Diabetes Mellitus on Mortality Risk in AECOPD

Overview

This systematic review and meta-analysis evaluates the impact of diabetes mellitus on mortality risk in patients experiencing acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The findings indicate that while diabetes may elevate mortality risk in univariate analyses, it does not appear to be an independent risk factor after multivariate adjustments.

Background

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide, with acute exacerbations significantly impacting patient outcomes. Diabetes mellitus is a common comorbidity in COPD patients, yet its influence on mortality during AECOPD remains controversial. Understanding this relationship is crucial for risk stratification and optimizing management strategies in affected patients.

Data Highlights

Study TypeSample SizeHR (95% CI)P-value
Univariate Analysis23,8831.45 (1.19, 1.77)< 0.0001
Multivariate Analysis23,8831.50 (0.45, 5.00)0.513

Key Findings

Expand on subgroup analysis results, particularly regarding hospitalized patients.

Clinical Implications

Clinicians should be aware that while diabetes may be associated with increased mortality in AECOPD patients, it may not be an independent risk factor after adjusting for confounders. This highlights the need for careful patient assessment and management strategies tailored to individual risk profiles.

Conclusion

The relationship between diabetes and mortality in AECOPD patients is complex and influenced by various factors. Further research is necessary to clarify the prognostic impact of diabetes in this population.

Related Resources & Content

  1. Frontiers | Impact of Diabetes Mellitus on Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A meta-analysis and systematic review
  2. The Journal of Clinical Endocrinology & Metabolism — Assessing the Efficacy and Safety of Dexamethasone in Hospitalized COVID-19 Patients with Diabetes: A Retrospective Cohort Analysis
  3. Infection — The Impact of Diabetes Mellitus on 90-Day Mortality Among Elderly Critically Ill Patients with COVID-19: Findings from a Multicenter Prospective Observational Study
  4. European Journal of Preventive Cardiology — New diagnosis of diabetes in patients with myocardial infarction or stroke: a systematic review and meta-analysis
  5. Frontiers in Endocrinology — Trends in acute myocardial infarction-related mortality among adults with type 1 vs. type 2 diabetes in the United States, 1999–2020
  6. 2025 GOLD Report
  7. Frontiers | Impact of Diabetes Mellitus on Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A meta-analysis and systematic review
  8. The clinical effectiveness of sodium-glucose co-transporter-2 inhibitors on prognosis of patients with chronic obstructive pulmonary disease and diabetes | Nature Communications

Original Source(s)

Related Content